全文获取类型
收费全文 | 20434篇 |
免费 | 1064篇 |
国内免费 | 197篇 |
专业分类
耳鼻咽喉 | 244篇 |
儿科学 | 460篇 |
妇产科学 | 234篇 |
基础医学 | 2620篇 |
口腔科学 | 295篇 |
临床医学 | 1204篇 |
内科学 | 5866篇 |
皮肤病学 | 394篇 |
神经病学 | 1490篇 |
特种医学 | 887篇 |
外科学 | 3411篇 |
综合类 | 68篇 |
预防医学 | 451篇 |
眼科学 | 404篇 |
药学 | 1077篇 |
中国医学 | 34篇 |
肿瘤学 | 2556篇 |
出版年
2023年 | 140篇 |
2022年 | 277篇 |
2021年 | 591篇 |
2020年 | 293篇 |
2019年 | 379篇 |
2018年 | 555篇 |
2017年 | 439篇 |
2016年 | 501篇 |
2015年 | 535篇 |
2014年 | 649篇 |
2013年 | 826篇 |
2012年 | 1296篇 |
2011年 | 1503篇 |
2010年 | 901篇 |
2009年 | 778篇 |
2008年 | 1313篇 |
2007年 | 1374篇 |
2006年 | 1396篇 |
2005年 | 1395篇 |
2004年 | 1406篇 |
2003年 | 1264篇 |
2002年 | 1255篇 |
2001年 | 185篇 |
2000年 | 132篇 |
1999年 | 197篇 |
1998年 | 269篇 |
1997年 | 224篇 |
1996年 | 165篇 |
1995年 | 171篇 |
1994年 | 148篇 |
1993年 | 139篇 |
1992年 | 98篇 |
1991年 | 103篇 |
1990年 | 72篇 |
1989年 | 82篇 |
1988年 | 56篇 |
1987年 | 47篇 |
1986年 | 51篇 |
1985年 | 49篇 |
1984年 | 53篇 |
1983年 | 49篇 |
1982年 | 37篇 |
1981年 | 47篇 |
1980年 | 39篇 |
1979年 | 18篇 |
1978年 | 28篇 |
1977年 | 25篇 |
1976年 | 15篇 |
1975年 | 18篇 |
1969年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
971.
Ito-Habe N Wada H Matsumoto T Ohishi K Toyoda H Ishikawa E Nomura S Komada Y Ito M Nobori T Katayama N 《International journal of hematology》2011,93(1):47-52
Thrombotic microangiopathy (TMA) is associated with vascular endothelial cell injury and is sometimes linked with poor outcome. Von Willebrand factor (VWF) propeptide (VWFpp) is considered to be a marker of vascular endothelial cell injury. The plasma levels of VWF, VWFpp, and thrombomodulin (TM) were evaluated for their use in the diagnosis of TMA in 75 patients with TMA. There were 30 TMA patients with marked decreases in ADAMTS13 (TMA/ADAMTS13) and 45 without the decrease (TMA/other). The plasma levels of TM, VWF, and VWFpp values were significantly high in patients with TMA, especially TMA/other group. The plasma levels of TM and VWFpp were significantly high in non-survivor with TMA. In the TMA/other group, the plasma levels of VWFpp were negatively correlated with ADAMTS13 activity. The plasma levels of TM correlated with the renal function, but the plasma levels of VWFpp did not. A ROC analysis indicated that VWFpp and TM were useful markers for the prediction of a poor outcome. These findings suggest that VWFpp is an useful marker for the diagnosis of TMA and for the prediction of poor outcome. 相似文献
972.
Shinichi YOSHIMURA Kazutaka UCHIDA Nobuyuki SAKAI Hiroshi YAMAGAMI Manabu INOUE Kazunori TOYODA Yuji MATSUMARU Yasushi MATSUMOTO Kazumi KIMURA Reiichi ISHIKURA Takeshi MORIMOTO 《Neurologia medico-chirurgica》2022,62(3):156
Endovascular therapy is strongly recommended for acute cerebral large vessel occlusion (LVO) with an Alberta stroke program early computed tomography score (ASPECTS) ≥6 due to occlusion of the internal carotid artery or M1 segment of the middle cerebral artery. However, the effect of endovascular therapy for patients with a large ischemic core with an ASPECTS ≤5 (0–5) was not established. A multicenter, randomized, open-label, parallel-group trial was conducted to investigate the superiority of endovascular therapy over medical therapy without endovascular therapy for a large ischemic core with ASPECTS (3–5). Patients were randomly assigned to receive endovascular therapy or without endovascular therapy at a ratio of 1:1. The primary outcome was a moderate functional outcome, defined as a modified Rankin scale (mRS; scores ranging from 0 [no symptoms] to 6 [death]) ≤3 after 90 days. The secondary outcomes were defined as ordinal mRS, good functional outcome (mRS ≤2), excellent functional outcome (mRS ≤1), mRS shift analysis after 90 days, and early improvement of neurological findings at 48 hours. A total sample size of 200 was estimated to provide a power of 0.9 with a two-sided alpha of 0.05, for the primary outcome, considering a 15% dropout rate. This randomized clinical trial reported the applicability of endovascular therapy in patients with acute cerebral LVO with a large ischemic core. 相似文献
973.
Shinji Ueno Yusuke Seino Shihomi Hidaka Ryuya Maekawa Yuko Takano Michiyo Yamamoto Mika Hori Kana Yokota Atsushi Masuda Tatsuhito Himeno Shin Tsunekawa Hideki Kamiya Jiro Nakamura Hitoshi Kuwata Haruki Fujisawa Megumi Shibata Takeshi Takayanagi Yoshihisa Sugimura Daisuke Yabe Yoshitaka Hayashi Atsushi Suzuki 《Nutrients》2022,14(5)
(1) Background: Protein stimulates the secretion of glucagon (GCG), which can affect glucose metabolism. This study aimed to analyze the metabolic effect of a high-protein diet (HPD) in the presence or absence of proglucagon-derived peptides, including GCG and GLP-1. (2) Methods: The response to HPD feeding for 7 days was analyzed in mice deficient in proglucagon-derived peptides (GCGKO). (3) Results: In both control and GCGKO mice, food intake and body weight decreased with HPD and intestinal expression of Pepck increased. HPD also decreased plasma FGF21 levels, regardless of the presence of proglucagon-derived peptides. In control mice, HPD increased the hepatic expression of enzymes involved in amino acid metabolism without the elevation of plasma amino acid levels, except branched-chain amino acids. On the other hand, HPD-induced changes in the hepatic gene expression were attenuated in GCGKO mice, resulting in marked hyperaminoacidemia with lower blood glucose levels; the plasma concentration of glutamine exceeded that of glucose in HPD-fed GCGKO mice. (4) Conclusions: Increased plasma amino acid levels are a common feature in animal models with blocked GCG activity, and our results underscore that GCG plays essential roles in the homeostasis of amino acid metabolism in response to altered protein intake. 相似文献
974.
Kazuomi Kario YookChin Chia Saulat Siddique Yuda Turana Yan Li ChenHuan Chen Jennifer Nailes Minh Van Huynh Peera Buranakitjaroen HaoMin Cheng Takeshi Fujiwara Satoshi Hoshide Michiaki Nagai Sungha Park Jinho Shin Jorge Sison Arieska Ann Soenarta Guru Prasad Sogunuru Apichard Sukonthasarn Jam Chin Tay Boon Wee Teo Kelvin Tsoi Narsingh Verma TzungDau Wang Yuqing Zhang JiGuang Wang 《Journal of clinical hypertension (Greenwich, Conn.)》2022,24(3):213
Asia is a large continent and there is significant diversity between countries and regions. Over the last 30 years, absolute blood pressure (BP) levels in Asia have increased to a greater extent than those in other regions. In diverse Asia‐Pacific populations, for choosing an Asia‐specific approach to hypertension management is important to prevent target organ damage and cardiovascular diseases. In this consensus document of HOPE Asia Network, we introduce seven action approaches for management of hypertension in Asia. 相似文献
975.
Gastric bleeding during cardiopulmonary bypass (CPB) is a rare but life-threatening complication for patients undergoing cardiac
surgery. We present a case of a patient undergoing coronary bypass grafting in whom we detected gastric bleeding by transesophageal
echocardiography (TEE) during CPB. After separation from CPB, bleeding was stopped by endoscopic clipping of the mucosa. If
a fluid deficit is noted and TEE reveals a hypoechoic space within the stomach, gastric bleeding might be suggested. 相似文献
976.
Takeshi Yoshikawa Takeshi Hara Hisashi Tsurumi Naoe Goto Masato Hoshi Junichi Kitagawa Nobuhiro Kanemura Senji Kasahara Hiroyasu Ito Masao Takemura Kuniaki Saito Mitsuru Seishima Tsuyoshi Takami Hisataka Moriwaki 《European journal of haematology》2010,84(4):304-309
Purpose: Introduction of rituximab has largely improved the prognosis of patients with diffuse large B‐cell lymphoma(DLBCL). Such change in therapeutic outcome necessitates the identification of additional prognostic factors to conventional indexes that have been validated for CHOP without rituximab. Indoleamine 2,3‐dioxygenase (IDO) exerts intense immunomodulatory effects because of enzymatic activities that catalyze the breakdown of the essential amino acid L‐tryptophan. The activity of IDO can be estimated by measuring the serum concentration of L ‐kynurenine. Here, we investigated the role of L ‐kynurenine as a prognostic marker in R‐CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) therapy. Experimental design: Data from 73 consecutive patients treated with eight cycles of R‐CHOP or R‐THP (tetrahydropyranyl adriamycin)‐COP between December 2002 and March 2007 were analyzed. L ‐kynurenine concentrations in serum samples obtained at admission were measured by high‐performance liquid chromatography. Results: The median serum L ‐kynurenine level was 1.575 μm (range 0.537–9.588). The complete response (CR) rates of patients with L ‐kynurenine <1.5 and ≥1.5 μm were 83% and 61%, respectively (P < 0.05). The three‐yr overall survival (OS) rates for patients with L ‐kynurenine <1.5 and ≥1.5 μm were 89% and 58%, respectively (P < 0.005). In addition, higher age, poor performance status, elevated serum lactate dehydrogenase, and unfavorable as well as revised International Prognosis Index were significantly worse factors for CR rate and OS. Multivariate analyses revealed only L ‐kynurenine as an independent prognostic factor for OS. Conclusions: Serum L ‐kynurenine might be a novel prognostic factor to determine the treatment outcome of DLBCL with the R‐CHOP regimen. 相似文献
977.
978.
Shouko Ono Mototsugu Kato Yuji Ono Aki Imai Takeshi Yoshida Yuichi Shimizu Masahiro Asaka 《Journal of gastroenterology and hepatology》2009,24(4):639-645
Background and Aim: Histamine 2 receptor antagonists and proton-pump inhibitors, drugs that are widely used for the treatment of acid-related diseases, have different clinical characteristics. The objective of this study was to compare the acid-suppressing effects of ranitidine hydrochloride and those of rabeprazole sodium at the first administration and re-administration after withdrawal.
Methods: The study was designed as an open-label, randomized, two-way cross-over trial. Seven Helicobacter pylori -negative healthy volunteers were enrolled in this study. Ranitidine hydrochloride (300 mg/day) or rabeprazole sodium (20 mg/day) was administered from days 1 to 7 and from days 11 to 13. The percentage of time with gastric pH < 4 and the median gastric pH were evaluated for 15 consecutive days by a Bravo capsule fixed to the stomach.
Results: On day 1, there was no significant difference between the acid-suppressing effects of the two drugs (ranitidine vs rabeprazole: not significant). Although rabeprazole sodium maintained a potent and stable effect from days 2 to 7 (ranitidine vs rabeprazole: P < 0.05), the effect of ranitidine hydrochloride was attenuated after day 4. In addition, the effect of ranitidine hydrochloride at re-administration was attenuated (days 11, 12, and 13 vs pre-administration: not significant).
Conclusion: In view of our observations, we expect symptoms associated with gastric acidity to be more adequately controlled with rabeprazole sodium in the short term when compared to ranitidine hydrochloride. 相似文献
Methods: The study was designed as an open-label, randomized, two-way cross-over trial. Seven Helicobacter pylori -negative healthy volunteers were enrolled in this study. Ranitidine hydrochloride (300 mg/day) or rabeprazole sodium (20 mg/day) was administered from days 1 to 7 and from days 11 to 13. The percentage of time with gastric pH < 4 and the median gastric pH were evaluated for 15 consecutive days by a Bravo capsule fixed to the stomach.
Results: On day 1, there was no significant difference between the acid-suppressing effects of the two drugs (ranitidine vs rabeprazole: not significant). Although rabeprazole sodium maintained a potent and stable effect from days 2 to 7 (ranitidine vs rabeprazole: P < 0.05), the effect of ranitidine hydrochloride was attenuated after day 4. In addition, the effect of ranitidine hydrochloride at re-administration was attenuated (days 11, 12, and 13 vs pre-administration: not significant).
Conclusion: In view of our observations, we expect symptoms associated with gastric acidity to be more adequately controlled with rabeprazole sodium in the short term when compared to ranitidine hydrochloride. 相似文献
979.
Extensive auricular necroses as an initial symptom of cryofibrinogenemia occurring secondary to gastric diffuse large B‐cell lymphoma 下载免费PDF全文
980.
Jun Nishikawa Masaaki Satake Kouichi Hamabe Yuki Fukagawa Yasuyuki Shirai Shu Kiyotoki Mari Saito Takeshi Okamoto Isao Sakaida 《Journal of gastroenterology and hepatology》2010,25(9):1514-1517
Background and Aim: Strip biopsy and endoscopic submucosal dissection (ESD) have been developed as a local treatment for early gastric cancer (EGC). However, the lesion criteria for the use of ESD, rather than strip biopsy, remain to be elucidated. Methods: On the basis of reviews of literature and our observations concerning the outcome of strip biopsy, we set the criteria for selecting strip biopsy and ESD as follows. The indications for strip biopsy were lesions less than 10 mm in size and located in the anterior wall or greater curvature of the lower and middle stomach. ESD was indicated for all other lesions. The validity of the criteria was then analyzed prospectively in 156 patients. The rate of en bloc R0 resection and local recurrence were evaluated. Results: Subsequently, 156 lesions were divided according to the criteria and were endoscopically resected by strip biopsy (n = 13) or ESD (n = 143). The en bloc R0 resection rates for the whole group and the strip biopsy and ESD groups was 93.5% (146/156), 92.3% (12/13), and 93.7% (134/143), respectively. None of the patients had suffered from local recurrence in either the strip biopsy or ESD groups. Conclusion: The validity of our criteria for selecting strip biopsy and ESD was verified. Our criteria exploit the advantages of both procedures and obtain better endoscopic therapy outcomes for EGC. 相似文献